Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00708526 · ClinicalTrials.gov registry record · NA
Improved Patient Recovery After Anesthesia With Hypercapnia Hyperpnoea
A NA study, sponsored by University of Utah.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT00708526: Completed NA study, sponsored by University of Utah.
NCT00708526 is a NA study that has completed, run by University of Utah. The registered enrollment target is 22 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00708526, a NA study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
The proposed study will measure the time from the end of surgery until the time patients meet the discharge criteria from the postoperative anesthesia care unit and the time from the end of surgery until the patients regained cognitive function after anesthesia.
Primary Outcome
average time in minutes from the time the surgeon finished closing the surgical incision until the time the investigator in the postoperative care unit determined that the patients meet the discharge criteria from the postoperative anesthesia care unit (their vital signs had been stable for at least 30 min, their pain scores were less than the tolerable pain scores, they could sit up without dizziness or nausea, and their Aldrete score was ≥8).
Interventions
- OTHER standard of care for phase one anesthesia care
- DEVICE Quick Emergence Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2008-03 |
| Est. Completion | 2008-11 |
| Phase | NA |
What the finished NCT00708526 record still lists
NCT00708526 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which standard of care for phase one anesthesia care is the first listed.
NCT00708526 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00708526 about?
NCT00708526 is a clinical study titled "Improved Patient Recovery After Anesthesia With Hypercapnia Hyperpnoea". The proposed study will measure the time from the end of surgery until the time patients meet the discharge criteria from the postoperative anesthesia care unit and the time from the end of surgery until the patients regained cognitive function after anesthesia.
What is the current status of trial NCT00708526?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2008-03. Estimated completion is 2008-11.
What interventions are being tested in trial NCT00708526?
The interventions under investigation include: standard of care for phase one anesthesia care (OTHER), Quick Emergence Device (DEVICE).
Who is sponsoring clinical trial NCT00708526?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00708526's enrollment target sits among peer trials
22 1756th of 2000 higher than 239 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia